Krystal Biotech, Inc. (BIT:1KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,836	4,352	3,166	1,909	1,532	967
Market Cap Growth	20.81%	37.47%	65.87%	24.59%	58.47%	13.17%
Enterprise Value	5,101	3,689	2,632	1,536	1,220	735
PE Ratio	34.42	50.54	320.10	-	-	-
PS Ratio	18.35	15.51	69.02	-	-	-
PB Ratio	6.02	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	6.02	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	41.35	37.81	-	-	-	-
P/OCF Ratio	38.86	36.51	-	-	-	-
EV/Sales Ratio	15.90	13.15	57.38	-	-	-
EV/EBITDA Ratio	36.82	36.14	-	-	-	-
EV/EBIT Ratio	37.48	37.01	-	-	-	-
EV/FCF Ratio	36.15	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.06	0.07	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Asset Turnover	0.34	0.31	0.07	-	-	-
Inventory Turnover	0.76	1.20	-	-	-	-
Quick Ratio	9.43	6.89	17.35	13.14	17.02	17.56
Current Ratio	10.14	7.28	17.77	13.30	17.18	17.80
Return on Equity (ROE)	19.66%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	8.91%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Capital (ROIC)	9.70%	7.41%	-9.22%	-13.38%	-9.73%	-8.21%
Return on Capital Employed (ROCE)	13.80%	10.80%	-12.40%	-22.90%	-11.60%	-11.20%
Earnings Yield	2.90%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	2.42%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-1.34%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.